BROOKS Intraday Analysis...

BROOKS Share Price

Open 102.00 Change Price %
High 103.90 1 Day -5.10 -5.03
Low 95.05 1 Week -7.20 -6.96
Close 96.20 1 Month 5.50 6.06
Volume 112945 1 Year -22.35 -18.85
52 Week High 144.00
52 Week Low 79.00
BROOKS Important Levels
Resistance 2 104.40
Resistance 1 101.02
Pivot 98.38
Support 1 91.38
Support 2 88.00
NSE INDIA Most Active Stocks
RCOM 13.35 -12.75%
JPASSOCIAT 14.20 -18.62%
ASHOKLEY 134.30 -9.50%
PNB 78.15 4.55%
RNAVAL 14.40 -6.49%
ICICIBANK 289.30 1.12%
SUZLON 8.70 -1.69%
GMRINFRA 17.00 -2.02%
SBIN 244.45 2.34%
STAR 341.00 -11.90%
More..
NSE INDIA Top Gainers Stocks
GREENFIRE 0.15 50.00%
UVSL 0.20 33.33%
DWARKESH 23.45 12.20%
SFL 1451.00 11.66%
SFL 1451.00 11.66%
SFL 1451.00 11.66%
REPRO 676.65 9.16%
DHAMPURSUG 93.05 8.89%
UTTAMSUGAR 86.00 8.04%
INDSWFTLAB 66.05 7.22%
More..
NSE INDIA Top Losers Stocks
NAKODA 0.15 -25.00%
KITEX 182.20 -19.36%
JPASSOCIAT 14.20 -18.62%
GMBREW 855.35 -16.73%
SPYL 0.25 -16.67%
MVL 0.25 -16.67%
MVL 0.25 -16.67%
SHIVATEX 387.80 -15.59%
IMFA 368.20 -14.54%
NACLIND 31.00 -14.48%
More..

Brooks Laboratories Limited (NSE: BROOKS)

BROOKS Technical Analysis 1.5
As on 21st May 2018 BROOKS Share Price closed @ 96.20 and we RECOMMEND Sell for LONG-TERM with Stoploss of 103.79 & Buy for SHORT-TERM with Stoploss of 92.15 we also expect STOCK to react on Following IMPORTANT LEVELS.
BROOKS Target for May
1st Target up-side 116.04
2nd Target up-side 130.99
3rd Target up-side 145.95
1st Target down-side 73.36
2nd Target down-side 58.41
3rd Target down-side 43.45
BROOKS Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 47.74 Sideways
MFI (14) MFI is 76.97 Sideways
CCI (20) CCI is -47.56 Sideways
WILLIAM %R (14) William %R is -72.44 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 122.75
10 Day Avg Volume Traded -80.81 % Less then 10 Day Average Volume
BROOKS Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
BROOKS Address
BROOKS
N/A
BROOKS Latest News
Stocks to Watch: NXP Semi, Hewlett-Packard, Johnson & Johnson   Wall Street Journal (blog)   - 02nd Mar 15
Brooks Labs standalone Dec '14 sales at Rs 23.68 crore   Moneycontrol.com   - 17th Feb 15
Tesco recalls fruit drinks over 'foreign bodies' and 'unusual smell'   Daily Mail   - 28th Jan 15
Sebi slaps Rs 11.80 cr penalty on Brooks Labs and 5 executives   Business Standard   - 12th Jan 15
Brooks Laboratories Ltd clarifies on SEBI order against the firm   Equity Bulls   - 05th Dec 14
Clarification sought from Brooks Laboratories Ltd   Hindu Business Line   - 03rd Dec 14
Sebi passes orders against 8 companies for non-disclosures in IPO   Economic Times   - 02nd Dec 14
Brooks Laboratories appoints SGCO & Co as statutory auditors   Moneycontrol.com   - 12th Aug 14
SEBI imposes Rs. 53.5 cr fine in Brooks Lab IPO case   Hindu Business Line   - 31st Dec 13
IPO Crackdown-2: Brooks Laboratories   Moneylife Personal Finance site and magazine   - 13th Jan 12
Interactive Technical Analysis Chart Brooks Laboratories Limited ( BROOKS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Brooks Laboratories Limited
BROOKS Business Profile
Brooks Labs is in the Pharmaceuticals sector. Brooks Laboratories Ltd. was established in 2002 and maintains its strong presence in the Pharmaceutical industry as a Contract Manufacturing Company since its inception. Brooks Laboratories Ltd is a Research and Development driven Pharmaceutical manufacturing company, in last 6 years company has successfully established itself as a reputed Contract Manufacturing company for latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups. The current market capitalisation stands at Rs 28.65 crore.The company has reported a standalone sales of Rs 25.20 crore and a Net Profit of Rs 1.9 crore for the quarter ended Sep 2013. The company management includes Atul Ranchal - Chairman, Rajesh Mahajan - Managing Director, D S Maity - Director & CEO, Rajnish Bedi - Independent Director, Bhaskar Sharma - Additional Director. It is listed on the BSE with a BSE Code of 533543 and the NSE with an NSE Code of BROOKS. Its Registered office is at Village Kishanpura, Nalagarh Road,,Baddi Solan District,Himachal Pradesh - 174101.